Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of “Moderate Buy” by Brokerages
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has received an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price […]
More Stories
Trump Says US Will Take Back Control of Panama Canal If US Interests Threatened
By Melanie Sun President-elect Donald Trump has said he will take back control of the Panama Canal from the nation’s...
Comparing Bath & Body Works (BBWI) & Its Competitors
Bath & Body Works (NYSE:BBWI – Get Free Report) is one of 27 publicly-traded companies in the “Retail stores, not...
Bion Environmental Technologies (OTCMKTS:BNET) Shares Cross Below 50-Day Moving Average – Here’s What Happened
Bion Environmental Technologies, Inc. (OTCMKTS:BNET – Get Free Report)’s share price passed below its 50-day moving average during trading on...
Market Vectors Chinese Renminbi/USD ETN (NYSEARCA:CNY) Shares Cross Below 50-Day Moving Average – Here’s What Happened
Market Vectors Chinese Renminbi/USD ETN (NYSEARCA:CNY – Get Free Report) shares crossed below its 50-day moving average during trading on...
Tiziana Life Sciences (LON:TILS) Share Price Passes Above 50-Day Moving Average – Should You Sell?
Tiziana Life Sciences PLC (LON:TILS – Get Free Report) passed above its 50-day moving average during trading on Friday ....
UK Oil & Gas (LON:UKOG) Stock Crosses Below 50-Day Moving Average – Should You Sell?
UK Oil & Gas PLC (LON:UKOG – Get Free Report) shares crossed below its 50-day moving average during trading on...